CAPTRUST Financial Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-61,000	Closed	-$9.3K	–	2766
2023 Q2	$9.3K	Hold	61,000	–	–	﹤0.01%	2486
2023 Q1	$8.75K	Buy	+61,000	New	+$9.76K	﹤0.01%	2270
2022 Q4	–	Sell	-61,000	Closed	-$11K	–	2237
2022 Q3	$11K	Buy	+61,000	New	+$32.8K	﹤0.01%	2031

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

CAPTRUST Financial Advisors's HGEN Position: Q3 2023 in Review

CAPTRUST Financial Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 61,000 shares — an estimated $9.3K sold.

CAPTRUST Financial Advisors first reported a position in HGEN in Q3 2022 and held it in 3 quarters. The position peaked at $11K in Q3 2022. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

CAPTRUST Financial Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
CAPTRUST Financial Advisors sold 61,000 HUMANIGEN, INC. shares in Q3 2023, an estimated $9.3K.
CAPTRUST Financial Advisors first reported a position in HUMANIGEN, INC. in Q3 2022 and held it in 3 quarters.
CAPTRUST Financial Advisors's HUMANIGEN, INC. position peaked at $11K in Q3 2022.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.